JJ
Johnson & Johnson Innovation - JJDC, Inc. disclosed a 5.3% stake in TRXB
Johnson & Johnson Innovation - JJDC, Inc. reported owning 5.3% of TRex Bio, Inc. (TRXB) (1,475,302 shares) in a Schedule 13G filed Oct 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.